Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Wy 21901
2. Wy-21901
3. Wy21901
1. Indoramine
2. 26844-12-2
3. Indoramina
4. Wy-21901
5. Wy 21901
6. N-[1-[2-(1h-indol-3-yl)ethyl]piperidin-4-yl]benzamide
7. Baratol
8. Indoramine;wy 21901
9. Benzamide, N-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)-
10. N-(1-(2-indol-3-ylethyl)-4-piperidyl)benzamide
11. 0z802hmy7h
12. Chembl279516
13. Doralese
14. Benzamide, N-(1-(2-indol-3-ylethyl)-4-piperidyl)-
15. Benzamide, N-[1-(2-indol-3-ylethyl)-4-piperidyl]-
16. Indoraminum
17. Benzamide, N-[1-[2-(1h-indol-3-yl)ethyl]-4-piperidinyl]-
18. Indoramine [inn-french]
19. Indoraminum [inn-latin]
20. Indoramina [inn-spanish]
21. N-[1-(2-indol-3-ylethyl)-4-piperidyl]benzamide
22. Ncgc00165810-01
23. Einecs 248-041-5
24. Brn 0494035
25. Unii-0z802hmy7h
26. Indoramin [usan:inn:ban]
27. 3-(2-(4-benzamidopiperid-1-yl)ethyl)indole
28. N-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)benzamide
29. 3-[2-(4-benzamidopiperidino)ethyl]indole
30. Indoramin [inn]
31. Indoramin [mi]
32. Indoramin (usan/inn)
33. Indoramin [usan]
34. Maybridge3_004972
35. 3-[2-(4-benzamido-1-piperidyl)ethyl]indole
36. Indoramin [who-dd]
37. Oprea1_130443
38. Schembl49517
39. Schembl49518
40. Gtpl501
41. Mls001182179
42. Zinc1567
43. Dtxsid7048370
44. Chebi:135470
45. Hms1445b22
46. Hms2851p23
47. Bdbm50033113
48. Ccg-41146
49. Nsc771684
50. Pdsp1_001099
51. Pdsp1_001423
52. Pdsp2_001083
53. Pdsp2_001407
54. Akos015994528
55. Af-0013
56. Db08950
57. Nsc-771684
58. Idi1_016359
59. Hy-12760
60. Smr000567879
61. Cs-0012358
62. D04531
63. L001292
64. Q408963
65. Sr-01000631243-1
66. N-(1-[2-(1h-indol-3-yl)ethyl]-4-piperidinyl)benzamide #
67. N-{1-[2-(1h-indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide
68. Indoraminn-{1-[2-(1h-indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide
69. N-{1-[2-(1h-indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide (indoramin)
70. N-{1-[2-(1h-indol-3-yl)-ethyl]-piperidin-4-yl}-benzamide(indoramin)
| Molecular Weight | 347.5 g/mol |
|---|---|
| Molecular Formula | C22H25N3O |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 347.199762429 g/mol |
| Monoisotopic Mass | 347.199762429 g/mol |
| Topological Polar Surface Area | 48.1 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 454 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
C - Cardiovascular system
C02 - Antihypertensives
C02C - Antiadrenergic agents, peripherally acting
C02CA - Alpha-adrenoreceptor antagonists
C02CA02 - Indoramin
ABOUT THIS PAGE
86
PharmaCompass offers a list of Indoramina API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Indoramina manufacturer or Indoramina supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Indoramina manufacturer or Indoramina supplier.
PharmaCompass also assists you with knowing the Indoramina API Price utilized in the formulation of products. Indoramina API Price is not always fixed or binding as the Indoramina Price is obtained through a variety of data sources. The Indoramina Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Indoramina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indoramina, including repackagers and relabelers. The FDA regulates Indoramina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indoramina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Indoramina supplier is an individual or a company that provides Indoramina active pharmaceutical ingredient (API) or Indoramina finished formulations upon request. The Indoramina suppliers may include Indoramina API manufacturers, exporters, distributors and traders.
Indoramina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indoramina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indoramina GMP manufacturer or Indoramina GMP API supplier for your needs.
A Indoramina CoA (Certificate of Analysis) is a formal document that attests to Indoramina's compliance with Indoramina specifications and serves as a tool for batch-level quality control.
Indoramina CoA mostly includes findings from lab analyses of a specific batch. For each Indoramina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indoramina may be tested according to a variety of international standards, such as European Pharmacopoeia (Indoramina EP), Indoramina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indoramina USP).
